Ferring Appoints New Board Member

Ferring Appoints New Board Member
13 May 2002 pulse

Ferring Appoints New Board Member

Lausanne, Switzerland – May 13th, 2002 –

The Board of Directors of Ferring announced today that Mr. Bernd Wolff has been appointed as a board member. Wolff becomes an outside director to the board.

He previously held the position of head of Company Financing and Controlling, Corporate Business Development, Corporate Treasury and Group CFO ad interim at Headquarters of F. Hoffmann-La Roche AG in Basel, Switzerland.

Mr. Wolff graduated with an MBA at University St. Gallen, Switzerland in 1973. He then served apprenticeships with Deutsche Bank AG in Germany and various assignments for family-owned companies. He joined Ciba-Geigy AG, today Novartis, in 1973 as Country Controller in Basel and for 2 years on different assignments in Singapore and Indonesia.

Mr. Wolff was then appointed as Finance Manager for the Roche Group in Indonesia in 1977. Upon return to Basel in 1980, he has since assumed numerous brief responsibilities including Pharma Marketing, Market Research, Product Management and also within Corporate Finance.

From 1991, Wolff was a member of the Roche Corporate Finance Board and since May 2001, was an ad interim member of the Corporate Executive Board. Since November 2001, Wolff works as an independent consultant for European and US companies.

”We are very happy to welcome Mr. Wolff to our board of directors,” said Frederik Paulsen, executive chairman of Ferring. ”His broad experience in finance and corporate business development will bring significant strength to Ferring and it’s continued growth.”

About Ferring Pharmaceuticals

Ferring is a research driven, speciality biopharmaceutical group active in global markets.  The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynecology, infertility and urology.

In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.

To learn more about Ferring or our products  please visit us at www.Ferring.com.

For more information, please contact

Sharmi Albrechtsen
Communication Manager, Ferring International Center
+45 28 78 72 09

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.


Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.


Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals


Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.


Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.


Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.